ATA’s Year in Thyroidology: A Virtual Experience
Purchase the session recordings to access this “best of” learning experience all from the convenience of your home or office. Access the speakers disclosures. Sessions recordings include:
Directed Therapies for Thyroid Nodules Satellite Course (Separate registration required. See below for agenda)
Embracing the Prognostic Value of Molecular Markers to Inform Thyroid Nodule Management eProduct Theater
- Erik K. Alexander, MD, Brigham & Women’s Hospital
This program is made possible with the support of ATA partner Veracyte, Inc.
New Therapeutics and Treatment Strategies for Advanced Thyroid Cancer
- Maria E. Cabanillas, MD, MD Anderson Cancer Center
- Lori J. Wirth, MD, Massachusetts General Hospital
- Mark Zafereo, Jr., MD, MD Anderson Cancer Center
Immunomodulators, Immunotherapies, and Their Effects on the Thyroid Gland
- Michael Yeh, MD, UCLA
- Melissa Lechner, MD, PhD, UCLA
- Mabel M. Ryder, MD, Mayo Clinic
Hypothyroidism and Combination Therapy
- Antonio Bianco, MD, PhD, University of Chicago
- Jacqueline Jonklaas, MD, PhD, Georgetown University
- James V. Hennessey, MD, Beth Israel Deaconess Medical Center
Thyroid Nodule Ultrasound Risk Stratification and the Promise of Artificial Intelligence
- Jill Langer, MD, University of Pennsylvania
- Naykky Singh Ospina, MD, University of Florida
Non-Surgical Treatment of Benign Nodules
- M. Regina Castro, MD, Mayo Clinic
- Jung Hwan Baek, MD, PhD, University of Ulsan College of Medicine, Asan Medical Center
- Stefano Spiezia MD, Ospedale del Mare
Trends in Managing Graves’ Disease
- Juan P. Brito Campana, M.B.B.S., Mayo Clinic
- Marius Stan, MD, Mayo Clinic
Meet the Professor Sessions
- “Current status of active surveillance in the US”
- Michael Tuttle, MD, Memorial Sloan Kettering
- Allen Ho, MD, Cedars-Sinai Medical Center
- “Sneak Peek at the ATA guidelines for thyroid nodules and thyroid cancer”
- Susan Mandel, MD, University of Pennsylvania
- Matthew Ringel, MD, Ohio State University
- “The de-escalation of care for thyroid nodules: progress and challenges”
- Louise Davies, MD, MS, The Dartmouth Institute
- Megan Haymart, MD, University of Michigan
- “What’s new in thyroid surgery for 2021”
- Martha A. Zeiger, MD, National Cancer Institute
- Quan-Yang Duh, MD, University of California San Francisco
Satellite Workshop – Also available on-demand!
Directed Therapies for Thyroid Nodules
Join Course Director Ralph P. Tufano, MD, MBA, FACS, Johns Hopkins University, and Co-Course Directors Jenifer Kuo, MD, MS, FACS, Columbia University and Leonardo Rangel, MD, Rio de Janeiro State University for this workshop with lectures, live cases on Hydrodissection and Moving ShotTechniques and discussion on future directions.
- ETOH ablation of Thyroid Nodules: Pearls and Pitfalls – Dev Abraham, MD, University of Utah
- What is RFA and How Does it Work? – Jonathon O. Russell, MD, FACS, Johns Hopkins University
- Selecting the Right Patients for Directed Therapy – Kepal Patel, MD, FACS, NYU Langone Health
- Optimizing Outcomes, Equipment and Setup of RFA – Jennifer Kuo, MD, MS, FACS, Columbia University
- RFA Techniques for Benign Nodules: Live Cases Hydrodissection and Moving Shot Techniques – Leonardo Rangel, MD, State University of Rio de Janeiro
- Future Directions: Parathyroid, PMC and Lymph Nodes – Catherine Sinclair, MD, Mount Sinai – New York
- The Korean RFA Experience : Lessons Learned – Jung Hwan Baek, MD, PhD, University of Ulsan College of Medicine, Asan Medical Center
- Toxic Thyroid Nodules: RFA, Surgery or RAI? – Stefano Spiezia MD, Ospedale del Mare
- Case Discussions – Emad Kandil, MD, Tulane University, Jose Higino Steck MD, PhD, University of Campinas Medical School and Erivelto Volpi, MD, PhD, Medical College of Nove de Julho University
- Ultrasound Considerations for Directed Therapies – Lisa Orloff, MD, Stanford Cancer Center
- LASER ablation for Thyroid Nodules – Stefano Spiezia MD, Ospedale del Mare
(Separate registration required)
M. Regina Castro, MD, Co-Chair
Michael W. Yeh, MD, Co-Chair
Joshua Klopper, MD
Naykky Singh Ospina, MD
Jennifer A. Sipos, MD
Marius N. Stan, MD
Mark Zafereo, MD
Endocrinologists, surgeons, PhDs, primary care physicians, physician assistants and nurse practitioners.
Please renew your ATA membership to take advantage of member rates. A valid 2021 membership is required to take advantage of member rates. Not a member? Join today!
|Non Member Trainees||$199|
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Colorado School of Medicine and the American Thyroid Association. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Colorado School of Medicine designates this internet live activity for a maximum of 12 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12 Medical Knowledge MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program (formerly known as MOC). It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.